• No results found

Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C induces epigenetic changes

N/A
N/A
Protected

Academic year: 2020

Share "Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C induces epigenetic changes"

Copied!
11
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Fig. 1 Study design and vitamin C levels at baseline and after patients had been randomized to 500 mg vitamin C or placebo
Table 1 Baseline characteristics of patients randomized for vitamin C (500 mg) or placebo supplement
Fig. 2 (See legend on next page.)
Fig. 2 Vitamin C supplement causes increased 5hmC/5mC changes in mononuclear myeloid cells in patients treated with 5-azacytidine
+2

References

Related documents

Such use constitutes evidence of bad faith registration and use pursuant to Policy ¶4(b)(iv). 22, 2003) (“Registration and use of a domain name that incorporates another’s mark

The court held that “a lawsuit against a public entity that arises from its statements or actions is potentially subject to the anti-SLAPP statute” and that “the campaign

Participation in a HOPE VI program serves as a possible remedy for displaced public housing residents. HOPE VI is a federally funded program in which local

Following graduation in December of 2017, Allison seeks to teach secondary mathematics at the high school level and obtain her Master’s Degree in Mathematics Education..

Based on the evaluation parameters, drug dissolution profile and release drug kinetics HF23 was found to be optimized formulation Lamivudine tablets were prepared

We explored their perspectives on decision space, capacities and accountability in the health sector functions of planning, financing and budget allocation, programme implementation

The activities of the PPBW are aimed at creating integrated computer tools to support the broadly defined efforts to improve public security.. The main focus